The physical activity paradox in cardiovascular disease and all-cause mortality: the contemporary Copenhagen General Population Study with 104 046 adults
Holtermann A, Schnohr P, Nordestgaard BG, Marott JL
Eur Heart J. 2021;42(15):1499-1511
Leggi
Diabetes and overweight/obesity are independent, nonadditive risk factors for in-hospital severity of COVID-19: an international, multicenter retrospective meta-analysis
Longmore DK, Miller JE, Bekkering S, et al.
Diabetes Care. 2021;dc202676
Leggi
A comparison of familial and sporadic type 1 diabetes among young patients
Karges B, Prinz N, Placzek K, et al.
Diabetes Care. 2021;dc201829.
Leggi
Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies
Zhang Y, Chen C, Pan X, et al.
BMJ. 2021;373:n604
Leggi
Type 2 diabetes subtype responsive to ACCORD intensive glycemia treatment
Mariam A, Miller-Atkins G, Pantalone KM, et al.
Diabetes Care. 2021;dc202700.
Leggi
Diabetes technologies in people with type 1 diabetes mellitus and disordered eating: a systematic review on continuous subcutaneous insulin infusion, continuous glucose monitoring and automated insulin delivery
Priesterroth L, Grammes J, Clauter M, Kubiak T
Diabet Med. 2021;e14581.
Leggi
Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
Schernthaner G
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00059-0.
Leggi
Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes
Reid L, Baxter F, Forbes S
Diabet Med. 2021;e14570
Leggi
Glycemic index, glycemic load, and cardiovascular disease and mortality
Jenkins DJA, Dehghan M, Mente A, et al.
N Engl J Med. 2021;384:1312-1322
Leggi
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
Khunti K, Knighton P, Zaccardi F, et al.
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00050-4.
Leggi